Thalidomide-O-amido-C6-NH2 (TFA), 500mg

N-(4-METHOXYPHENYL)-6-METHYL-4-PYRIMIDINAMINE, 95.0%, 1g

(R)-3-Amino-3-(4-cyanophenyl)propanoic acid, 95.0%, 250mg

5-Bromo-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxylic acid, 95+%, 1g

Tetrahydro-2(1H)-pyrimidinone, 95.0%, 500g

Foglio d'argento, foglio, 100 x 100 x 0,1 mm, 1 pezzo, cartone

Methyl 2-bromo-4-fluorobenzo[d]thiazole-6-carboxylate, 95.0%, 1g

tert-Butyl 3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxylate, 97%, 250mg

[(4',4'-ETHYLENEDIOXY)CYCLOHEXYL]METHYL METHANESULFONATE, 95.0%, 1g

3-Chloro-pyrazine-2-carboxylic acid ethyl ester, 95.0%, 1g

tert-Butyl 3-oxo-2,3-dihydro-1H-pyrazole-1-carboxylate, 98%, 250mg

Thiobenzoic Acid, >93.0%(T), 500g

(4-Benzhydrylpiperazin-1-yl)(1,5-dimethyl-1H-pyrazol-3-yl)methanone, 98.0%, 50mg